Sung-Hwan Cho
Chief Executive Officer at CHOA PHARMACEUTICAL CO., LTD.
Net worth: 2 M $ as of 30/05/2024
Profile
Sung-Hwan Cho is currently the Vice Chairman & Co-Chief Executive Officer at ChoA Pharmaceutical Co., Ltd.
and the President & Chief Executive Officer at Medipharm.
He has an undergraduate degree from Korea University and a graduate degree from Chung-Ang University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2023 | 1,849,162 ( 5.97% ) | 2 M $ | 30/05/2024 |
Sung-Hwan Cho active positions
| Companies | Position | Start |
|---|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Chief Executive Officer | - |
Medipharm
 Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Chief Executive Officer | - |
Training of Sung-Hwan Cho
| Korea University | Undergraduate Degree |
| Chung-Ang University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Stock Market
- Insiders
- Sung-Hwan Cho
